In a study led by Notre Dame professor Reginald Hill, medical scientists focused on FDA-approved drugs to find out why many of them don’t work on pancreatic cancer. The team found that blocking the release of exosomes may help make chemotherapy more effective. Read more . . .
Researchers at the University of Notre Dame say they have uncovered a new approach for treating pancreatic cancer.